DCPH - Deciphera Pharmaceuticals EPS beats by $0.53 beats on revenue August, 02 2019 07:27 AM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals (NASDAQ:DCPH): Q2 GAAP EPS of -$0.56 beats by $0.53.More news on: Deciphera Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...